Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) — Oakland, California

Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) is a clinical research site located in Oakland, California, United States 94611.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) has participated in 1 clinical trials.

Therapeutic areas: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oakland

Browse all research sites in California · View every site in Oakland

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077)?

Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) conducted?

Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) has 1 clinical trials on record. Their work covers Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.

Is Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) accredited by Crixeo Clinical Trials?

Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.